References

1. Data on file.

2. Reimbursement rates may vary based upon geographical location, third party payer changes and other factors, and are subject to change in the future.

3. Standards of Medical Care in Diabetes - 2006. Diabetes Care, Vol. 29, Supplement, January 1, 2006.

4. Miller CD et al., Rapid A1C availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26:1158-1163.

5. Cagliero E et al., Immediate feedback of HbA1C levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999;

6. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2002. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2003. 22: 1785-1789.

7. NGSP Certification testing was performed using A1CNow InView which is now called A1CNow+ due to a change of the product name which occurred in 2006.

8. The diabetes control and complications trial research group: the effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.

9. UK prospective diabetes study group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS33) Lancet 352: 837-853, 1998.

10. web.missouri.edu/~diabetes/ngsp/ghbmbg/ghbmbg.htm

11. Diabetes Care 2002;25:275-8g